Literature DB >> 9344476

Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain.

H Kawashima1, E Kusunose, C M Thompson, H W Strobel.   

Abstract

We previously reported the cDNA cloning of three new forms of P450, CYP4F4, CYP4F5, and CYP4F6, from a rat brain cDNA library. In the present study, we expressed CYP4F4 and CYP4F5 in Escherichia coli using the pCWOri expression vector with a modification of their N-terminal amino acid sequences and the incorporation of a C-terminal [His]4 tag to aid in purification. CYP4F5 recombinant protein was purified to a specific content of 7.7 nmol/mg protein from the membrane fraction of E. coli and showed omega-hydroxylation activity toward leukotriene B4 (LTB4), a chemical mediator of inflammation. On the other hand, the solubilized membrane fraction of CYP4F4-expressed recombinant protein catalyzed the omega-hydroxylation of prostaglandin A1, prostaglandin E1, and 6-trans-LTB4 as well as LTB4. The effects of the peroxisome proliferator, clofibrate, on mRNA expression of CYP4F4, 4F5, and 4F6 were studied by Northern blot analysis. The expression levels of the mRNA of these CYP4Fs were shown to be reduced by clofibrate in liver. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344476     DOI: 10.1006/abbi.1997.0342

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  In vitro metabolism of chlorpromazine by cytochromes P450 4F4 and 4F5 and the inhibitory effect of imipramine.

Authors:  C L Boehme; H W Strobel
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

Review 2.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

Review 3.  Conflicting roles of 20-HETE in hypertension and renal end organ damage.

Authors:  Chao Zhang; George W Booz; Qing Yu; Xiaochen He; Shaoxun Wang; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-07       Impact factor: 4.432

Review 4.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

5.  Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.

Authors:  Irina Alecu; Alaa Othman; Anke Penno; Essa M Saied; Christoph Arenz; Arnold von Eckardstein; Thorsten Hornemann
Journal:  J Lipid Res       Date:  2016-11-21       Impact factor: 5.922

Review 6.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

7.  CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury.

Authors:  Ying Wang; Jing Zhao; Auinash Kalsotra; Cheri M Turman; Raymond J Grill; Pramod K Dash; Henry W Strobel
Journal:  J Neurotrauma       Date:  2008-10       Impact factor: 5.269

Review 8.  Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology.

Authors:  Daniel W Nebert; Christopher L Karp
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

9.  Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes.

Authors:  Auinash Kalsotra; Sayeepriyadarshini Anakk; Chad L Brommer; Yasushi Kikuta; Edward T Morgan; Henry W Strobel
Journal:  Arch Biochem Biophys       Date:  2007-03-15       Impact factor: 4.013

10.  Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.

Authors:  Matthew Birnie; Ryan Morrison; Ramatoulie Camara; Kenneth I Strauss
Journal:  BMC Genomics       Date:  2013-05-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.